Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.
@article{Ramalho2002FivePO, title={Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.}, author={A. Ramalho and S. Beck and M. Meyer and D. Penque and G. Cutting and M. Amaral}, journal={American journal of respiratory cell and molecular biology}, year={2002}, volume={27 5}, pages={ 619-27 } }
Estimates of the level of transcripts from the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) gene required to develop a CF phenotype range from 4-20% of normal. Due to the importance of obtaining reliable data on this issue for therapeutic strategies, we developed a novel polymerase chain reaction-based method to quantify CFTR transcripts and applied it to the analysis of nasal epithelium RNA of five patients with CF and the 3272-26A>G/F508del genotype. We calculated that 8.2… CONTINUE READING
Figures, Tables, and Topics from this paper
164 Citations
Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicing mutations causing cystic fibrosis
- Biology, Medicine
- European Journal of Human Genetics
- 2014
- 16
- PDF
CFTR Cl- channel function in native human colon correlates with the genotype and phenotype in cystic fibrosis.
- Biology, Medicine
- Gastroenterology
- 2004
- 100
Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides
- Medicine, Biology
- Human mutation
- 2016
- 45
- PDF
Functional stability of rescued delta F508 cystic fibrosis transmembrane conductance regulator in airway epithelial cells.
- Biology, Medicine
- American journal of respiratory cell and molecular biology
- 2010
- 52
Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors
- Medicine, Biology
- International journal of molecular sciences
- 2019
- 5
- PDF
Residual function of cystic fibrosis mutants predicts response to small molecule CFTR modulators.
- Biology, Medicine
- JCI insight
- 2018
- 33
- PDF
The holy grail of cystic fibrosis research: pharmacological repair of the F508del-CFTR mutation.
- Medicine
- Annals of translational medicine
- 2015
- 6
What’s new in cystic fibrosis? From treating symptoms to correction of the basic defect
- Medicine
- European Journal of Pediatrics
- 2008
- 80
References
SHOWING 1-10 OF 48 REFERENCES
The molecular basis of partial penetrance of splicing mutations in cystic fibrosis.
- Biology, Medicine
- American journal of human genetics
- 1997
- 162
Cystic fibrosis patients with the 3272‐26A→G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane
- Biology, Medicine
- Human mutation
- 1999
- 62
- PDF
A delta F508 mutation in mouse cystic fibrosis transmembrane conductance regulator results in a temperature-sensitive processing defect in vivo.
- Biology, Medicine
- The Journal of clinical investigation
- 1996
- 146
- PDF
A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.
- Medicine
- The New England journal of medicine
- 1994
- 407
A 32‐bp deletion (2991del32) in the cystic fibrosis gene associated with CFTR mRNA reduction
- Biology, Medicine
- Human mutation
- 1994
- 9
Higher proportion of intact exon 9 CFTR mRNA in nasal epithelium compared with vas deferens.
- Biology, Medicine
- Human molecular genetics
- 1997
- 92
- PDF
Cystic fibrosis patients with the 3272-26A>G splicing mutation have milder disease than F508del homozygotes: a large European study
- Biology, Medicine
- Journal of medical genetics
- 2001
- 42
Identification of a splice site mutation (2789+5 G>A) associated with small amounts of normal CFTRmRNA and mild cystic fibrosis
- Biology, Medicine
- Human mutation
- 1997
- 82
Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA
- Biology, Medicine
- Nature Genetics
- 1993
- 486
Complex cystic fibrosis allele R334W‐R1158X results in reduced levels of correctly processed mRNA in a pancreatic sufficient patient
- Biology, Medicine
- Human mutation
- 1996
- 25